1.

HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster

2.

HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster

3.

HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster

1.

P576 Real-world effectiveness and safety of risankizumab in patients with moderate-to-severe multi-refractory Crohn’s disease: a Belgian multi-centric cohort study

1.

Belgian Experience with Direct Acting Antivirals in People Who Inject Drugs

1.

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon...

1.

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon...

1.

Hepatitis B virus infection in Belgium: preliminary results of the Belgian Association for the Study of the Liver (BASL) registry of HBsAg chronic carriers

2.

Hepatitis B virus infection in Belgium: preliminary results of the Belgian Association for the Study of the Liver (BASL) registry of HBsAg chronic carriers

3.

Hepatitis B virus infection in Belgium: preliminary results of the Belgian Association for the Study of the Liver (BASL) registry of HBsAg chronic carriers

1.

Hepatitis B virus and hepatitis C virus infection in Belgium: similarities and differences in epidemic and initial management

1.

HBV infection in Belgium: results of the BASL observatory of 1456 HBsAg carriers.

1.

P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registry

1.

Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registry